Gemigliptin (tartrate hydrate)
Gemigliptin (LC15-0444) tartrate hydrate is a selective, reversible and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor, with an IC50 of 10.3 nM for human recombinant DPP-4. Gemigliptin tartrate hydrate exhibits potent anti-glycation properties. Gemigliptin tartrate hydrate can be used for the research of advanced glycation end products (AGE) -related diabetic complications[1][2].
Product Specifications
Product Name Alternative
LC15-0444 (tartrate hydrate)
UNSPSC
12352005
Target
Dipeptidyl Peptidase
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Purity
99.83
Smiles
OC([C@H](O)[C@@H](O)C(O)=O)=O.O=C1N(C[C@@H](N)CC(N2CCC3=C(C(F)(F)F)N=C(C(F)(F)F)N=C3C2)=O)CC(F)(F)CC1.O.[1.5]
Molecular Formula
C18H19F8N5O2.C4H6O6.3/2H2O
Molecular Weight
666.49
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-14892B/Gemigliptin-tartrate-hydrate-SDS-MedChemExpress.pdf
Scientific Category
Reference compound2
Clinical Information
No Development Reported
CAS Number
[1375415-82-9]
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
